Dahong Zhang

727 citations
55 papers · 435 indexed · h-index 13
Topics
Bladder and Urothelial Cancer Treatments (12 papers)Urological Disorders and Treatments (11 papers)Renal cell carcinoma treatment (7 papers)

In The Last Decade

Dahong Zhang

48 papers receiving 429 citations

Peers

Dahong Zhang
Comparison fields: 5 of 77
  • Surgery 197
  • Pulmonary and Respiratory Medicine 137
  • Oncology 94
  • Molecular Biology 81
  • Urology 52
Replace Yoram Dekel with:
Yoram Dekel Israel
Ning Kang China
Matthew D. Katz United States
Toshitsugu Oka Japan
Alfred Krebs United States
Hiroaki Itatani Japan
C C Anunobi Nigeria
Thomas A. Longo United States
Peyman Mohammadi Torbati Iran
Mark A. Wainstein United States
Dahong Zhang relative to Yoram Dekel Israel Yoram Dekel's profile →
Citations per field
00.5×3.7×
Yoram Dekel · 1×
Citations per year

Countries citing papers authored by Dahong Zhang

Since Specialization
Citations

This map shows the geographic impact of Dahong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahong Zhang more than expected).

Fields of papers citing papers by Dahong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dahong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahong Zhang. The network helps show where Dahong Zhang may publish in the future.

Co-authorship network of co-authors of Dahong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Dahong Zhang. A scholar is included among the top collaborators of Dahong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dahong Zhang. Dahong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 3
4 15
5 22
6 2
7 4
8 6
9 7
10 7
11 4
12 0
13 9
14 6
15 1
16 24
17 2
18 19
19
Experience of transperitoneal laparoscopic for massive perirenal hematoma
1
20
Middle and upper segmental ureterolithotomy with laparoscopy
1

About Dahong Zhang

Dahong Zhang is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 55 papers that have together received 435 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (12 papers), Urological Disorders and Treatments (11 papers) and Renal cell carcinoma treatment (7 papers). The work is most often cited by research in Urology (52 citations), Surgery (197 citations) and Pulmonary and Respiratory Medicine (137 citations). Dahong Zhang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Qi Zhang, Wing‐Fu Lai, Shuai Wang, Pu Zhang, Alin Ji, Mi Zhou, Yuelong Zhang, Xiang He, Xiaolong Qi and Guoqing Wu. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026